Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Clinical Trials
COVID
Dermatology
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Immunodeficiencies
Influenza
Insurance Reimbursement
Medicare
Medicines
Mental Health
Therapeutics
Vaccines
Washington Report
Women’s Disorders
Industry Insight
All Industry Insight
Artificial Intelligence
Autoimmune Disorders
Biosimilars
Cancer
Chronic Illness
COVID
Dermatology
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Immunodeficiencies
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Mental Health
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Women’s Disorders
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Fall 2017 - Innovation
Download Issue
Share
Up Front
Publisher's Corner
From Technologies to Models: A Changing Medical Landscape
By Patrick M. Schmidt
Features
Revolutionizing Patient Care with Digital Technology
By
Meredith Whitmore
Concierge Medicine: Reinventing Primary Care
By
Trudie Mitschang
Increasing Patient Engagement Through Online Health Records and Apps
By
Amy Scanlin, MS
Addressing Central Pain Syndrome
By
BSTQ Staff
Myths and Facts: E-Cigarettes
By
Ronale Tucker Rhodes, MS
BioTrends Watch
Washington Report
Supreme Court Rules in Favor of Faith-Based Hospitals’ Exemption from ERISA
More Small Practices Exempt from MACRA Under New Draft Rule
Report Shows Hospital-Acquired Conditions Continue to Decline
NIH Awards Grant to Study the Connection Between Autism and Autoimmunity During Pregnancy
HHS Renames AIDS.gov to HIV.gov
Drug Companies Can Be Fined for Overcharging Hospitals Under 340B Drug Discount Program
VA Rule Expands Scope of Advanced-Practice Registered Nurses
Reimbursement FAQs
How Proposed 2018 OPPS Payment Rules Impact Pharmacy
Industry News
FDA Approves First Drug to Treat Giant Cell Arteritis
Octapharma USA’s NUWIQ Receives FDA Approval for Expanded Vial Strengths
Recombinant Quadrivalent Flu Vaccine More Effective in Older Adults
Sanofi Pasteur Acquires Protein Sciences
Study Shows Microneedle Patch Influenza Vaccine Is Effective and Painless
Public Attitudes Toward Unvaccinated Children and Their Mothers Depends on Motivation Not to Vaccinate
New Study Supports CDC Recommendation for Two-Dose HPV Vaccine in Children
ADMA Biologics Acquires Biotest’s Therapy Business Unit
BCG Vaccine Could Permanently Reverse Type 1 Diabetes
Study Shows Influenza May Increase Risk of Developing Parkinson’s
Novo Nordisk’s Rebinyn Approved by FDA to Treat Hemophilia B
BioFocus
Industry Insight
Flublok: A Potent New Weapon Against the Shape-Shifting Influenza Virus
By Keith Berman, MPH, MBA
Patient Profile
Telemedicine: A Patient’s Perspective
By Trudie Mitschang
Physician Profile
Telemedicine: A Corporate Perspective
By Trudie Mitschang
Disease Profile
Update on Pulmonary Arterial Hypertension
By Jim Trageser
BioSources
BioResearch
Co-Administration of Albumin with Lactulose Reverses Hepatic Encephalopathy and Reduces Mortality in Liver Cirrhosis
IVIG Highly Protective in Ferrets After Challenge with Severe Pandemic pH1N1 and Avian H5N1 Influenza Strains